The Zirela nebuliser handset is a device from PARI's eFlow® Technology platform that is specifically optimised for the nebulisation of Quinsair 240 mg nebuliser solution. For detailed information about Quinsair please refer to the package leaflet of the medicine.
The Zirela nebuliser handset with an eBase® Controller is intended to administer Quinsair as an aerosol for inhalation.
The Zirela nebuliser handset is indicated to administer Quinsair to treat lung infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF).
For the Zirela nebuliser handset no contraindication is known to PARI Pharma GmbH. Take note of contraindications of the medicine in the Quinsair package leaflet.
Use of the nebuliser handset
The Zirela nebuliser handset must only be used in accordance with its intended purpose. For reasons of hygiene and to avoid cross-infections, the Zirela nebuliser handset must only be used by one patient.